Johns Hopkins HIV Guide →Brand Names

Telbivudine

Janessa M. Smith, Pharm.D., BCPS, Paul A. Pham, Pharm.D.
Pediatric Dosing Author: Alice Jenh Hsu, PharmD, BCPS, AQ-ID
Telbivudine is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Treatment of chronic hepatitis B (HBeAg-negative or -positive) with ongoing viral replication and evidence of transferase elevation or histologically active disease.

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: July 8, 2018

Citation

TY - ELEC T1 - Telbivudine ID - 545198 A1 - Smith,Janessa,Pharm.D., BCPS AU - Pham,Paul,Pharm.D. Y1 - 2018/07/08/ PB - Johns Hopkins HIV Guide UR - https://www.unboundmedicine.com/medline/view/Johns_Hopkins_HIV_Guide/545198/all/Telbivudine ER -